SCI Abstract

search
Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
Lung cancer patients are at increased risk of venous thromboembolism (VTE) and arterial thrombosis, particularly when trea...
Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition
Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition
Cancer patients are at an elevated risk of bleeding and ischemic events. There are limited comparative real-world data on ...
Thrombin generation and clot lysis time to predict outcomes in patients undergoing transcatheter aortic valve implantation
Thrombin generation and clot lysis time to predict outcomes in patients undergoing transcatheter aortic valve implantation
Transcatheter aortic valve implantation (TAVI) is an established treatment method in patients with severe aortic stenosis ...
Left atrial appendage occlusion in patients with cancer
Left atrial appendage occlusion in patients with cancer
Atrial fibrillation (AF) and malignancy share a complex relationship, significantly complicating patient management. Patie...
Treatment of isolated distal deep vein thrombosis: an international survey of healthcare professionals
Treatment of isolated distal deep vein thrombosis: an international survey of healthcare professionals
Isolated distal deep venous thrombosis (iDDVT) is an infra-popliteal DVT without pulmonary embolism (PE). It is a common c...
Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma
Venous thromboembolic complications in patients newly diagnosed with cholangiocarcinoma
Cholangiocarcinoma (CCA) is an uncommon cancer, with limited data available on the incidence of cancer-associated thrombos...
Associations between fibrinogen levels and the risk of all-cause mortality: a long-term cohort study
Associations between fibrinogen levels and the risk of all-cause mortality: a long-term cohort study
Although prior research has investigated the link between fibrinogen and mortality risk, there is a notable lack of long-t...
Association between stable angina pectoris and gastric cancer: two-sample bidirectional mendelian randomization study
Association between stable angina pectoris and gastric cancer: two-sample bidirectional mendelian randomization study
To explore the possible causal link between stable angina pectoris (SAP) and gastric cancer (GC) through Mendelian randomi...
Advancements in research on the thrombo-inflammation mechanisms mediated by factor XII in ischemic stroke
Advancements in research on the thrombo-inflammation mechanisms mediated by factor XII in ischemic stroke
Ischemic stroke (IS) is a major cause of mortality and disability, with thrombo-inflammation constituting a core pathophys...
The current status and future perspective of extended anticoagulation therapy for cancer-associated venous thromboembolism
The current status and future perspective of extended anticoagulation therapy for cancer-associated venous thromboembolism
Cancer-associated venous thromboembolism (VTE) is one of important complications in cancer patients, with implications for...
New interest in fibrinogen as an ischemic risk factor
New interest in fibrinogen as an ischemic risk factor
Platelet-fibrin clot formation is a key process in acute arterial thrombosis. The relationship between thrombin-induced pl...
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases
Authors and AffiliationsUniversity of Sao Paulo Medical School, Sao Paulo, BrazilBárbara Gomes Barion & Thaís Dourado ...
Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity
Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity
• Hospitalized patients may exhibit discordance in aPTT and anti-Xa activities while on UFH. • In this study, ...
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Factor XIIa (FXIIa) is a plasma serine protease within the contact activation pathway. Inhibiting FXIIa could offer a viab...